Development of novel monoclonal antibodies for evaluation of transmembrane prostate androgen-induced Protein 1 (TMEPAI) expression patterns in gastric cancer /M. S. Karbyshev, E. S. Grigoryeva, V. V. Volkomorov [et.al.]

Электронный ресурс
Другой Автор
Karbyshev, Mikhail S.
Volkomorov, Viktor V.
Kremmer, Elisabeth
Huber, Alexander
Mitrofanova, Irina V.
Kaigorodova, Evgeniya V.
Zavyalova, Marina V.
Kzhyshkowska, Julia G.
Cherdyntseva, Nadezhda V.
Grigoryeva, Evgeniya S.
Choynzonov, Evgeny L.
Источник
Pathology & oncology research 2017 Vol. 24, № 2. P. 427-438
Аннотация
Transmembrane prostate androgen-induced protein 1 (TMEPAI) is a single-span membrane protein, functionally involved in transforming growth factor beta signaling pathway. The particular protein presented in cells in three isoforms, which differs in the length of the soluble N-terminal extracellular domain, making it challenging for the immunochemical recognition. By using quantitative real-time polymerase chain reaction, we identified significant upregulation of PMEPA1 gene expression in malignant tissues of patients with gastric adenocarcinoma. The main part of commercially available anti-TMEPAI antibodies are having polyclonal nature or not suitable for immunocytochemical localization of target protein in tissue specimens. Hence, we decide to generate a set of novel rat monoclonal antibodies (mAb) directed against conservative C-terminal cytoplasmic epitope. Immunoblotting analysis showed that monoclonal antibodies, 2E1, 6C6, and 10A7 were able to recognize specifically target protein in transiently transfected HEK293T and CHO-K1 cells. Especially established mAb, named 10A7, showed the excellent binding ability to target protein in immunohistochemistry. By using developed antibodies, we observed pronounced expression of TMEPAI in normal gastric epithelial cells while tumor cells from gastric adenomas, and adenocarcinoma samples were mostly negative for target protein expression. Also, we found that gastric epithelium cells lose the TMEPAI expression concurrently with severe dysplasia progression, which probably caused by a mechanism involving specific microRNA.
Всего оценка: 0
Нет записей для отображения.
 
 
 
03430nab a2200445 c 4500
001
 
 
vtls000629818
003
 
 
RU-ToGU
005
 
 
20180621114600.0
007
 
 
cr |
008
 
 
180620|2017    hu      s         a eng dd
024
7
$a 10.1007/s12253-017-0247-x $2 doi
035
$a to000629818
039
9
$a 201806211146 $b cat202 $c 201806201551 $d VLOAD $y 201806201541 $z VLOAD
040
$a RU-ToGU $b rus $c RU-ToGU
245
1
0
$a Development of novel monoclonal antibodies for evaluation of transmembrane prostate androgen-induced Protein 1 (TMEPAI) expression patterns in gastric cancer $c M. S. Karbyshev, E. S. Grigoryeva, V. V. Volkomorov [et.al.]
504
$a Библиогр.: 47 назв.
520
3
$a Transmembrane prostate androgen-induced protein 1 (TMEPAI) is a single-span membrane protein, functionally involved in transforming growth factor beta signaling pathway. The particular protein presented in cells in three isoforms, which differs in the length of the soluble N-terminal extracellular domain, making it challenging for the immunochemical recognition. By using quantitative real-time polymerase chain reaction, we identified significant upregulation of PMEPA1 gene expression in malignant tissues of patients with gastric adenocarcinoma. The main part of commercially available anti-TMEPAI antibodies are having polyclonal nature or not suitable for immunocytochemical localization of target protein in tissue specimens. Hence, we decide to generate a set of novel rat monoclonal antibodies (mAb) directed against conservative C-terminal cytoplasmic epitope. Immunoblotting analysis showed that monoclonal antibodies, 2E1, 6C6, and 10A7 were able to recognize specifically target protein in transiently transfected HEK293T and CHO-K1 cells. Especially established mAb, named 10A7, showed the excellent binding ability to target protein in immunohistochemistry. By using developed antibodies, we observed pronounced expression of TMEPAI in normal gastric epithelial cells while tumor cells from gastric adenomas, and adenocarcinoma samples were mostly negative for target protein expression. Also, we found that gastric epithelium cells lose the TMEPAI expression concurrently with severe dysplasia progression, which probably caused by a mechanism involving specific microRNA.
653
$a рак желудка
653
$a иммуногистохимия
653
$a биомаркеры
653
$a моноклональные антитела
653
$a трансмембранный белок
655
4
$a статьи в журналах
700
1
$a Karbyshev, Mikhail S.
700
1
$a Volkomorov, Viktor V.
700
1
$a Kremmer, Elisabeth
700
1
$a Huber, Alexander
700
1
$a Mitrofanova, Irina V.
700
1
$a Kaigorodova, Evgeniya V.
700
1
$a Zavyalova, Marina V.
700
1
$a Kzhyshkowska, Julia G.
700
1
$a Cherdyntseva, Nadezhda V.
700
1
$a Grigoryeva, Evgeniya S.
700
1
$a Choynzonov, Evgeny L.
773
0
$t Pathology & oncology research $d 2017 $g Vol. 24, № 2. P. 427-438 $x 1219-4956
852
4
$a RU-ToGU
856
7
$u http://vital.lib.tsu.ru/vital/access/manager/Repository/vtls:000629818
908
$a статья
999
$a VIRTUA               
999
$a VTLSSORT0010*0030*0050*0070*0080*0240*0350*0390*0400*2450*5040*5200*6530*6531*6532*6533*6534*6550*7000*7009*7001*7002*7003*7004*7005*7006*7007*7008*70010*7730*8520*8560*9080*9992
Нет комментариев.
Предмет
статьи в журналах
Резюме
Transmembrane prostate androgen-induced protein 1 (TMEPAI) is a single-span membrane protein, functionally involved in transforming growth factor beta signaling pathway. The particular protein presented in cells in three isoforms, which differs in the length of the soluble N-terminal extracellular domain, making it challenging for the immunochemical recognition. By using quantitative real-time polymerase chain reaction, we identified significant upregulation of PMEPA1 gene expression in malignant tissues of patients with gastric adenocarcinoma. The main part of commercially available anti-TMEPAI antibodies are having polyclonal nature or not suitable for immunocytochemical localization of target protein in tissue specimens. Hence, we decide to generate a set of novel rat monoclonal antibodies (mAb) directed against conservative C-terminal cytoplasmic epitope. Immunoblotting analysis showed that monoclonal antibodies, 2E1, 6C6, and 10A7 were able to recognize specifically target protein in transiently transfected HEK293T and CHO-K1 cells. Especially established mAb, named 10A7, showed the excellent binding ability to target protein in immunohistochemistry. By using developed antibodies, we observed pronounced expression of TMEPAI in normal gastric epithelial cells while tumor cells from gastric adenomas, and adenocarcinoma samples were mostly negative for target protein expression. Also, we found that gastric epithelium cells lose the TMEPAI expression concurrently with severe dysplasia progression, which probably caused by a mechanism involving specific microRNA.